TriSalus Life Sciences (TLSI) Cash & Current Investments (2020 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Cash & Current Investments of $56.6 million for Q1 2026, up 335.02% year-over-year from $13.0 million in Q1 2025, and up 176.69% quarter-over-quarter from $20.4 million in Q4 2025.
TriSalus Life Sciences (TLSI) Cash & Current Investments (2020 - 2026) Analysis & Trends
TriSalus Life Sciences' Cash & Current Investments history runs 7 years deep, the most recent figure standing at $56.6 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 335.02% year-over-year to $56.6 million; the TTM figure through Mar 2026 stood at $56.6 million (up 335.02% YoY), while the FY2025 annual figure was $20.4 million, up 139.75% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $56.6 million, up from $20.4 million in the prior quarter.
- The five-year high for Cash & Current Investments was $56.6 million in Q1 2026, with the low at $69182.0 in Q2 2022.
- The 5-year median for Cash & Current Investments is $11.8 million (2023), against an average of $14.8 million.
- The sharpest annual moves came in 2022 and 2024: Cash & Current Investments slumped 89.24% in 2022, then jumped 15750.93% in 2024.
- TriSalus Life Sciences' Cash & Current Investments stood at $9.4 million in 2022, then increased by 25.1% to $11.8 million in 2023, then retreated by 27.61% to $8.5 million in 2024, then surged by 139.75% to $20.4 million in 2025, then surged by 176.69% to $56.6 million in 2026.
- Business Quant data shows TLSI's Cash & Current Investments at $56.6 million in Q1 2026, $20.4 million in Q4 2025, and $22.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 482.30 Mn |
| 10 | TriSalus Life Sciences | 304.89 Mn | 258.60 Mn | 9.90 Mn | 46.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.29 Mn |
| Mar 31, 2026 | 56.55 Mn |
| Dec 31, 2025 | 20.44 Mn |
| Sep 30, 2025 | 22.69 Mn |
| Jun 30, 2025 | 26.49 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Dec 31, 2024 | 8.53 Mn |
| Sep 30, 2024 | 11.29 Mn |
| Jun 30, 2024 | 16.48 Mn |
| Mar 31, 2024 | 3.97 Mn |
| Dec 31, 2023 | 11.78 Mn |
| Sep 30, 2023 | 21.38 Mn |
| Jun 30, 2023 | 103,975.00 |
| Mar 31, 2023 | 136,798.00 |
| Dec 31, 2022 | 9.41 Mn |
| Jun 30, 2022 | 69,182.00 |
| Jun 30, 2021 | 642,944.00 |
| Mar 31, 2021 | 1.13 Mn |
| Dec 31, 2020 | 1.33 Mn |